Jafron Biomedical Co Ltd
SZSE:300529
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Salesforce Inc
NYSE:CRM
|
Technology
|
| US |
|
UiPath Inc
NYSE:PATH
|
Technology
|
| US |
|
General Motors Co
NYSE:GM
|
Automobiles
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Pharmaceuticals
|
| US |
|
Baxter International Inc
NYSE:BAX
|
Health Care
|
| US |
|
Marathon Petroleum Corp
NYSE:MPC
|
Energy
|
| US |
|
Valero Energy Corp
NYSE:VLO
|
Energy
|
| US |
|
VICI Properties Inc
NYSE:VICI
|
Real Estate
|
| CA |
|
Shopify Inc
NYSE:SHOP
|
Technology
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
Pharmaceuticals
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Micron Technology Inc
NASDAQ:MU
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.6
37.82
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Salesforce Inc
NYSE:CRM
|
US |
|
|
UiPath Inc
NYSE:PATH
|
US |
|
|
General Motors Co
NYSE:GM
|
US |
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
US |
|
|
Baxter International Inc
NYSE:BAX
|
US |
|
|
Marathon Petroleum Corp
NYSE:MPC
|
US |
|
|
Valero Energy Corp
NYSE:VLO
|
US |
|
|
VICI Properties Inc
NYSE:VICI
|
US |
|
|
Shopify Inc
NYSE:SHOP
|
CA |
|
|
Merck & Co Inc
NYSE:MRK
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Micron Technology Inc
NASDAQ:MU
|
US |
This alert will be permanently deleted.
Jafron Biomedical Co Ltd
Total Receivables
Jafron Biomedical Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Total Receivables
¥120m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Receivables
¥50.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Receivables
¥1.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
3%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Receivables
¥4.6B
|
CAGR 3-Years
24%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Total Receivables
¥2.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Receivables
¥3.7B
|
CAGR 3-Years
56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jafron Biomedical Co Ltd
Glance View
Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. The company is headquartered in Zhuhai, Guangdong and currently employs 2,887 full-time employees. The company went IPO on 2016-08-02. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Company’s products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Company’s products are applied in uremia, poisoning, severe liver diseases, autoimmune diseases, as well as multisystem organ failure, among others. The Company’s products are applied in 31 provinces, more than 3000 hospitals in China.
See Also
What is Jafron Biomedical Co Ltd's Total Receivables?
Total Receivables
120m
CNY
Based on the financial report for Jun 30, 2024, Jafron Biomedical Co Ltd's Total Receivables amounts to 120m CNY.
What is Jafron Biomedical Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
-9%
Over the last year, the Total Receivables growth was -33%. The average annual Total Receivables growth rates for Jafron Biomedical Co Ltd have been -28% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
